ARCHIVES

Clolar Approved for Pediatric Refractory/Relapsed ALL

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

January 2, 2004

Interim Analysis Suggests Paclical Can Reduce Blood Levels

August 26, 2011

Implantable Drug Delivery Device Offers Better Pain Relief

September 27, 2002

CMS Issues Coverage Decision For Provenge in Prostate Cancer

July 29, 2011

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

October 28, 2005

In Brief: NIH AIDS William Paul To Step down; Aldige to Lead NCCR; Rimer Joins NCI

October 10, 1997